Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving blood clotting factor
Reexamination Certificate
2005-06-07
2005-06-07
Gitomer, Ralph (Department: 1651)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving blood clotting factor
Reexamination Certificate
active
06902904
ABSTRACT:
A method, kit, system and reagent for performing coagulation assays with higher sensitivity and greater dynamic range is provided which involves the use of one or more metal compounds that interact with calcium binding sites in the blood coagulation cascade, particularly lanthanide compounds, manganese compounds and magnesium compounds. A Protein C reagent, kit, and assay method is also provided using the same type of metal compounds to provide greater detection sensitivity and dynamic range between samples.
REFERENCES:
patent: 4849340 (1989-07-01), Oberhardt
patent: 5001069 (1991-03-01), Bartl et al.
patent: 5110727 (1992-05-01), Oberhardt
patent: 5350676 (1994-09-01), Oberhardt et al.
patent: 5552296 (1996-09-01), Adema et al.
patent: 5601991 (1997-02-01), Oberhardt
patent: 5658723 (1997-08-01), Oberhardt
patent: 5670329 (1997-09-01), Oberhardt
patent: 5677133 (1997-10-01), Oberhardt
patent: 6030840 (2000-02-01), Mullinax et al.
patent: 6136271 (2000-10-01), Lorincz et al.
patent: 6245573 (2001-06-01), Spillert
patent: 6395501 (2002-05-01), Rosen et al.
patent: 6482653 (2002-11-01), Kraus et al.
patent: 2002/0132370 (2002-09-01), Lassen et al.
patent: 2003/0027235 (2003-02-01), Kraus et al.
patent: 2689640 (1993-10-01), None
patent: WO 98/39654 (1998-11-01), None
Blinc A. Flow Through Clots Determines the Rate and Pattern of Fibrinolysis. Thrombosis and Haemostasis 71(2)230-235, 1994.
A. Broekmans, et al., “Congenital Protein C Defifciency and Venous Thromboembolism, A Study of Three Dutch Families”, The New England Journal of Medicine, vol. 309, No. 6, pp. 340-344, 1983.
J. Griffin, et al., “Protein C, an Antithrombotic Protein, Is Reduced in Hospitalized Patients with Intravascular Coagulation”, BlOOD, vol. 60, No. 1 (Jul.), pp. 261-264, 1982.
R. Marlar, et al., “Serial Studies of Protein C and Its Plasma Inhibitor in Patients with Disseminated Intravascular Coagulation”, BLOOD, vol. 66, No. 1 (Jul.), pp. 59-63. 1985.
“Protein C in the Treatment of coagulopathy in meningococcal disease”, The Lancet, vol. 347, p. 1767, Jun. 1996.
O. P. Smith, et al., “Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans”, The Lancet, vol. 350, pp. 1590-1593, Nov. 1997.
R. Favier, et al., “Simultaneous administration of antithrombin III and protein C concentrates for the treatment of a devastating coagulopathy in a child”, Hematol. Cell Ther., vol. 40, pp. 67-70, 1998.
J. Parkinson, et al., “Stable Expression of a Secretable Deletion Mutant of Recombinant Human Thrombomodulin in Mammalian Cells”, The Journal of Biological Chemistry, vol. 265, No. 21, pp. 12602-12610, Jul. 1990.
B. Gerlitz, et al., “Identification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: potential regulation of functionality by glycosyltransferase competition for serine474”, Biochem J., vol. 295, pp. 131-140, 1993.
D. T. Berg, et al., “High-Level Expression of Secreted Protein s form Cells Adapted to Serum-Free Suspension Culture”, BIOTECHNIQUES, vol. 14, No. 6, pp. 972-978, 1993.
J. Parkinson, et al., “Structure-Function Studies of the Epidermal Growth Factor Domains of Human Thrombomodulin”, Biochemical and Biophysical Research Communications, vol. 185, No. 2, pp. 567-576, 1992.
C. E. White, et al., “Large-scale expression, purification and characterization of small fragments of thrombomodulin: the roles of the sixth domain and of methionine 388”, Protein Engineering, vol. 8, No. 11, pp. 1177-1187, 1995.
D. E. Jackson, et al., “Purification and characterization of two forms of soluble thrombomodulin from human urine”, Eur. J. Biochem., vol. 221, pp. 1079-1087, 1994.
S. M. Richards, et al., “Quantitative and Functional Assays compared for Determination of Zymogen and Activated Human Protein C”, Clin. Chem. vol. 36, No. 11, pp. 1892-1896, 1990.
L. Bajzar, et al. “Both Cellular And Soluble Forms of Thrombomodulin Inhibit Fibrinolysis by Potentiating The Activation of Thrombin-activable Fibrinolysis Inhibitor”, J. Biol. Chem., vol. 273, No. 5, 1998. Abstract Only.
M. F. Hockin, et al., “Inactivation on human umbilical vein endothelial cells”, Arterioscler., Thromb., Vasc. Biol., vol. 17, No. 11, 1997. Abstract Only.
A. J. Gale, et al., “Nonenzymic anticoagulant activity of the mutant seine protease Ser360Ala-activated protein C mediated by factor Va”, Protein Science, vol. 6, No. 1, 1997. Abstract Only.
S. Yu, et al., “Construction, Expression, and Properties of a Recombinant chimeric Human Protein C with Replacementof Its Growth Factor-like Domains by those of Human Coagulation Factor IX”, BIOCHEMISTRY, vol. 33, No. 3, 1994. Abstract Only.
C. L. Orthner, et al., “A sensitive and facile assay for the measurement of activated protein C activity levels in vivo”, Thromb. Haemostasis, vol. 69, No. 5, 1993. Abstract Only.
K. G. Mann, et al., “Active site-specific immunoassays”, BLOOD, vol. 76, No. 4, 1990. Abstract Only.
K. F. Stocker, et al., “Snake protein C activator, methods of preparation and use thereof”, US Patent. Abstract Only.
S. Nakamura, et al., “Assay methods for protein C (and protein S)”, Rinsho Byori, Rinji Zokan, vol. 70, 1987, Abstract Only.
G. A. Soff, et al., “Protein C levels in nephrotic syndrome: use of a new enzyme-linked immunoadsorbent assay for protein C antigen”, Am. J. Hematol., vol. 22, No. 1, 1986. Abstract Only.
R. M. Bertina, et al., “The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency”, Throb. Haemostasis, vol. 51, No. 1, 1984. Abstract Only.
A. Blinc, et al., Flow Through Clots Determines the Rate and Pattern of Fibrinolysis. Thrombosis and Haemostasis, 1994, vol. 71, No. 2, pp. 230-235.
Written Opinion, PCT/US02/03357, International filing date: Feb. 7, 2002, 4 pages.
Cutsforth Gwyn A.
Mahan Donald E.
Gitomer Ralph
Pharmanetics Incorporated
LandOfFree
Coagulation assay reagents containing lanthanides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Coagulation assay reagents containing lanthanides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coagulation assay reagents containing lanthanides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3486346